AP1G2
protein-codingadaptor related protein complex 1 subunit gamma 2, the group of Clathrin/coatomer adaptor, adaptin-like, N-terminal domain containing|Adaptor related protein complex 1
Gene summary
Adaptins are important components of clathrin-coated vesicles transporting ligand-receptor complexes from the plasma membrane or from the trans-Golgi network to lysosomes. The adaptin family of proteins is composed of four classes of molecules named alpha, beta-, beta prime- and gamma- adaptins. Adaptins, together with medium and small subunits, form a heterotetrameric complex called an adaptor, whose role is to promote the formation of clathrin-coated pits and vesicles. The protein encoded by this gene is a gamma-adaptin protein and it belongs to the adaptor complexes large subunits family. This protein along with the complex is thought to function at some trafficking step in the complex pathways between the trans-Golgi network and the cell surface. [provided by RefSeq, Aug 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~8.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AP1G2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003917.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | ||||
| missense | 1 | 129 | 8 | 138 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 0 | 1 | 135 | 8 | 0 | 144 |
Highest pathogenic variant AF is 0.00005391691
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003908.1 | 21 | MANE Select | |
| Ensembl | ENSP00000380309.3 | 21 | MANE Select | |
| RefSeq | NP_001269403.1 | 11 | Standard | |
| RefSeq | NP_001269404.1 | 18 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| ap1g2 | Danio rerio | Structure: blood cell Quality: mislocalised abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysosome - Homo sapiens (human)
- Lysosome Vesicle Biogenesis
- Clathrin derived vesicle budding
- trans-Golgi Network Vesicle Budding
- Vesicle-mediated transport
Biological Process
- intracellular protein transport
- viral process
- vesicle-mediated transport
Molecular Function
- protein binding
Cellular Component
- Golgi membrane
- Golgi apparatus
- Golgi-associated vesicle
- endosome membrane
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000308724
- Coding exons
- 21
- Length
- 8506
- Individuals with no LoFs
- 125090
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 656
- Defined
- 125748
- p
- 0.00262
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.391 | 449 | 473 | 0.949 | 0.0000273 | 5042 |
| Missense (PolyPhen) | 185 | 187.49 | 0.98669 | 2124 | ||
| Synonymous | 1.02 | 167 | 185 | 0.905 | 0.00000955 | 1691 |
| Loss of Function | 0.267 | 43 | 44.9 | 0.957 | 0.00000263 | 435 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0019 | 0.0019 | notable |
| Latino/Admixed American | 0.0028 | 0.0027 | notable |
| Ashkenazi Jewish | 0.0038 | 0.0038 | notable |
| East Asian | 0.0011 | 0.0011 | notable |
| Finnish | 0.0010 | 0.0010 | notable |
| European (Non-Finnish) | 0.0033 | 0.0033 | notable |
| South Asian | 0.0019 | 0.0018 | notable |
| Other | 0.0038 | 0.0038 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May function in protein sorting in late endosomes or multivesucular bodies (MVBs). {ECO:0000269|PubMed:9733768}.;
Recessive Scores
- pRec
- 0.0972
Intolerance Scores
- LoFtool
- 0.976
- RVIS EVS
- -1.24
- RVIS percentile EVS
- 5.52
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.911
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |